‘We Have been Flying Blind’: A Dr.’s Account of a Lady’s J.&J. Vaccine-Associated Blood Clot Case

0
20
‘We Were Flying Blind’: A Dr.’s Account of a Woman’s J.&J. Vaccine-Related Blood Clot Case

Dr. Lipman said when the team examined her blood samples the pieces started to fit and they discovered that she appeared to have the same problem that they knew had occurred in the UK and Europe after patients took the AstraZeneca Received the vaccine. mostly in young women. They switched from heparin to another blood thinner and followed instructions from doctors in the UK who had treated AstraZeneca recipients with a similar disorder.

Hoping for more information about the condition and a possible association with the Johnson & Johnson vaccine, Dr. Lipman to call the Food and Drug Administration for an emergency number. It was a weekend and he said the person who answered told him that there was no one available to help and that the line should be kept open for emergencies.

"I thought this was an emergency," said Dr. Lipman. "She hang up."

He called back to ask how to reach Janssen, who makes the Johnson & Johnson vaccine. That information was not available, and he said the person who responded also told him that the F.D.A. could not provide advice on patient care.

A F.D.A. Spokeswoman Stephanie Caccomo said in an email, "We will investigate further to ensure that Doctors F.D.A. To get help are getting the help they are looking for."

Dr. Lipman said the pharmacist at his hospital filed a report online to the Centers for Disease Control and Prevention in early April, but the agency didn't contact him until this week to inquire about the case. The agency declined to comment on whether or not to work with Dr. Lipman had communicated, a spokeswoman, Kristen Nordlund, said via email.

At a Wednesday meeting of a C.D.C. The advisory board Johnson & Johnson and Dr. Tom Shimabukuro, a security expert for the agency, both presented data on the young woman in Nevada. After the meeting, Nevada officials issued a statement saying the meeting was the first time they had heard of a case in their state – they had previously informed the public that no cases had been reported – and they asked "federal partners" why the state had not been informed.

At the Nevada hospital, an interventional radiologist inserted a tube through blood vessels into the young woman's brain and aspirated the clots with a device. More clots later formed and he performed the procedure again.

LEAVE A REPLY

Please enter your comment!
Please enter your name here